These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 16557781)

  • 1. Macrophage Migration Inhibition Studies with Cells from Mice Vaccinated with Cell Walls of Mycobacterium bovis BCG: Relationship Between Inhibitory Activity of Lung Cells and Resistance to Airborne Challenge with Mycobacterium tuberculosis H37Rv.
    Yamamoto K; Anacker RL; Ribi E
    Infect Immun; 1970 Jun; 1(6):595-9. PubMed ID: 16557781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship of footpad sensitivity to purified protein derivatives and resistance to airborne infection with Mycobacterium tuberculosis of mice vaccinated with mycobacterial cell walls.
    Anacker RL; Ribi E; Tarmina DF; Fadness L; Mann RE
    J Bacteriol; 1969 Oct; 100(1):51-7. PubMed ID: 4981063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between tuberculin hypersensitivity and cellular immunity to infection in mice vaccinated with viable attenuated Mycobacterial cells or with Mycobacterial ribonucleic acid preparations.
    Neiburger RG; Youmans GP; Youmans AS
    Infect Immun; 1973 Jul; 8(1):42-7. PubMed ID: 4198103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Macrophage activation and resistance to pulmonary tuberculosis.
    Lefford MJ
    Infect Immun; 1980 May; 28(2):508-15. PubMed ID: 6772560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Macrophage Migration Inhibition Studies with Cells from Mice Vaccinated with Cell Walls of Mycobacterium bovis BCG: Characterization of the Experimental System.
    Yamamoto K; Anacker RL
    Infect Immun; 1970 Jun; 1(6):587-94. PubMed ID: 16557780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune response to Mycobacterium bovis bacille Calmette Guérin infection in major histocompatibility complex class I- and II-deficient knock-out mice: contribution of CD4 and CD8 T cells to acquired resistance.
    Ladel CH; Daugelat S; Kaufmann SH
    Eur J Immunol; 1995 Feb; 25(2):377-84. PubMed ID: 7875199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Mycobacterium bovis BCG vaccination on interleukin-1 beta and RANTES mRNA expression in guinea pig cells exposed to attenuated and virulent mycobacteria.
    Jeevan A; Yoshimura T; Foster G; McMurray DN
    Infect Immun; 2002 Mar; 70(3):1245-53. PubMed ID: 11854207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of the mouse Bcg, Tbc-1 and xid genes on resistance and immune responses to tuberculosis infection and efficacy of bacille Calmette-Guérin (BCG) vaccination.
    Nikonenko BV; Apt AS; Mezhlumova MB; Avdienko VG; Yeremeev VV; Moroz AM
    Clin Exp Immunol; 1996 Apr; 104(1):37-43. PubMed ID: 8603530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Priming but not boosting with plasmid DNA encoding mycolyl-transferase Ag85A from Mycobacterium tuberculosis increases the survival time of Mycobacterium bovis BCG vaccinated mice against low dose intravenous challenge with M. tuberculosis H37Rv.
    Romano M; D'Souza S; Adnet PY; Laali R; Jurion F; Palfliet K; Huygen K
    Vaccine; 2006 Apr; 24(16):3353-64. PubMed ID: 16488518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M; Shirakawa T
    Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A DNA prime-live vaccine boost strategy in mice can augment IFN-gamma responses to mycobacterial antigens but does not increase the protective efficacy of two attenuated strains of Mycobacterium bovis against bovine tuberculosis.
    Skinner MA; Ramsay AJ; Buchan GS; Keen DL; Ranasinghe C; Slobbe L; Collins DM; de Lisle GW; Buddle BM
    Immunology; 2003 Apr; 108(4):548-55. PubMed ID: 12667217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aerosol immunization by alginate coated mycobacterium (BCG/MIP) particles provide enhanced immune response and protective efficacy than aerosol of plain mycobacterium against M.tb. H37Rv infection in mice.
    Nagpal PS; Kesarwani A; Sahu P; Upadhyay P
    BMC Infect Dis; 2019 Jul; 19(1):568. PubMed ID: 31262260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunogenicity of cell walls from various mycobacteria against airborne tuberculosis in mice.
    Brehmer W; Anacker RL; Ribi E
    J Bacteriol; 1968 Jun; 95(6):2000-4. PubMed ID: 4970218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differentiation between Mycobacterium bovis BCG-vaccinated and M. bovis-infected cattle by using recombinant mycobacterial antigens.
    Buddle BM; Parlane NA; Keen DL; Aldwell FE; Pollock JM; Lightbody K; Andersen P
    Clin Diagn Lab Immunol; 1999 Jan; 6(1):1-5. PubMed ID: 9874655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polyfunctional CD4 T-cells correlate with in vitro mycobacterial growth inhibition following Mycobacterium bovis BCG-vaccination of infants.
    Smith SG; Zelmer A; Blitz R; Fletcher HA; Dockrell HM
    Vaccine; 2016 Oct; 34(44):5298-5305. PubMed ID: 27622301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mycobacterium bovis BCG substrains confer different levels of protection against Mycobacterium tuberculosis infection in a BALB/c model of progressive pulmonary tuberculosis.
    Castillo-Rodal AI; Castañón-Arreola M; Hernández-Pando R; Calva JJ; Sada-Díaz E; López-Vidal Y
    Infect Immun; 2006 Mar; 74(3):1718-24. PubMed ID: 16495544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T-cell response to mycobacterial proteins: a comparative study of tuberculous and control immunoblots of Mycobacterium tuberculosis and M. bovis BCG.
    Bassey EO; Life PF; Catty D; Gaston JS; Kumararatne DS
    Tuber Lung Dis; 1996 Apr; 77(2):146-53. PubMed ID: 8762849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of pulmonary granuloma formation in mice by treatment with Mycobacterial protoplasm and immuno-suppressants and its relation to protection against aerosol infection with virulent Mycobacterium tuberculosis.
    Yamamoto K; Granger DL; Brehmer W; Azuma I; Ribi E
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1981; 250(1-2):127-41. PubMed ID: 6797153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mycobacterium bovis BCG and purified protein derivative-induced reduction in the CD80 expression and the antigen up-take function of dendritic cells from patients with cervical cancer.
    Manickam A; Sivanandham M
    Eur J Obstet Gynecol Reprod Biol; 2011 Dec; 159(2):413-7. PubMed ID: 21824715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The live Mycobacterium tuberculosis phoP mutant strain is more attenuated than BCG and confers protective immunity against tuberculosis in mice and guinea pigs.
    Martin C; Williams A; Hernandez-Pando R; Cardona PJ; Gormley E; Bordat Y; Soto CY; Clark SO; Hatch GJ; Aguilar D; Ausina V; Gicquel B
    Vaccine; 2006 Apr; 24(17):3408-19. PubMed ID: 16564606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.